Information Provided By:
Fly News Breaks for November 18, 2019
Nov 18, 2019 | 08:50 EDT
Canaccord analyst Mark Massaro raised his price target on Quidel to $75 from $70 following investor meetings with the CEO. The analyst said 2020 is a big new product launch year but that 2021 will be even bigger. The company's strategy is to leverage its large installed base of Sofia analyzers and continue to roll out new assays with the expected rolllout of Savannah in 2021 poised to mark another inflection for the company. Massaro reiterated his Buy rating on Quidel shares.
News For QDEL From the Last 2 Days
There are no results for your query QDEL